Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lesniak

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
The Journal of Clinical Investigation|January 31, 2023
Next-generation antigen-presenting cell immune therapeutics for gliomasCatalina Lee-Chang, Maciej S Lesniak
Expert Review of Neurotherapeutics|November 9, 2005
Surgical management of high-grade gliomasJoseph C Hsieh, Maciej S Lesniak
Neurological Research|October 4, 2005
Immunotherapy for malignant glioma: current approaches and future directionsChristian W Sikorski, Maciej S Lesniak
Current Neurology and Neuroscience Reports|March 20, 2002
Drug delivery to tumors of the central nervous systemM S Lesniak, R Langer, H Brem
Cancer Cell & Microenvironment|July 11, 2015
Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistanceMarc Deheeger, Maciej S Lesniak, Atique U Ahmed
Journal of Neurosurgery|September 12, 2006
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumorsAbdeljabar El Andaloussi, Yu Han, Maciej S Lesniak
Expert Review of Anticancer Therapy|September 29, 2006
Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumorsWael Musleh, Adam M Sonabend, Maciej S Lesniak
Neurosurgery Clinics of North America|December 1, 2009
Challenges in clinical design of immunotherapy trials for malignant gliomaCleo E Rolle, Sadhak Sengupta, Maciej S Lesniak
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivoAbdeljabar El Andaloussi, Yu Han, Maciej S Lesniak
Expert Review of Anticancer Therapy|January 10, 2008
Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant gliomaAdam M Sonabend, Karen Dana, Maciej S Lesniak
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
The Journal of Clinical Investigation|January 31, 2023
Next-generation antigen-presenting cell immune therapeutics for gliomasCatalina Lee-Chang, Maciej S Lesniak
Expert Review of Neurotherapeutics|November 9, 2005
Surgical management of high-grade gliomasJoseph C Hsieh, Maciej S Lesniak
Neurological Research|October 4, 2005
Immunotherapy for malignant glioma: current approaches and future directionsChristian W Sikorski, Maciej S Lesniak
Current Neurology and Neuroscience Reports|March 20, 2002
Drug delivery to tumors of the central nervous systemM S Lesniak, R Langer, H Brem
Cancer Cell & Microenvironment|July 11, 2015
Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistanceMarc Deheeger, Maciej S Lesniak, Atique U Ahmed
Journal of Neurosurgery|September 12, 2006
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumorsAbdeljabar El Andaloussi, Yu Han, Maciej S Lesniak
Expert Review of Anticancer Therapy|September 29, 2006
Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumorsWael Musleh, Adam M Sonabend, Maciej S Lesniak
Neurosurgery Clinics of North America|December 1, 2009
Challenges in clinical design of immunotherapy trials for malignant gliomaCleo E Rolle, Sadhak Sengupta, Maciej S Lesniak
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivoAbdeljabar El Andaloussi, Yu Han, Maciej S Lesniak
Expert Review of Anticancer Therapy|January 10, 2008
Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant gliomaAdam M Sonabend, Karen Dana, Maciej S Lesniak
Pageof 28